Health-care Workers’ Willingness to Pay for COVID-19 Vaccines in Eastern Ethiopia: Using Contingent Valuation Method

References

• Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. doi:10.1038/s41586-020-2008-3
   PubMed Web of Science ®Google Scholar
• Umakanthan S, Sahu P, Ranade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–758. doi:10.1136/postgradmedj-2020-138234
   PubMed Web of Science ®Google Scholar
• Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi:10.1016/S0140-6736(20)30154-9
   PubMed Web of Science ®Google Scholar
• Suryavanshi N, Kadam A, Dhumal G, et al. Mental health and quality of life among healthcare professionals during the COVID‐19 pandemic in India. Brain Behav. 2020;10(11):e01837. doi:10.1002/brb3.1837
   PubMed Web of Science ®Google Scholar
• Serrano-Ripoll MJ, Meneses-Echavez JF, Ricci-Cabello I, et al. Impact of viral epidemic outbreaks on mental health of healthcare workers: a rapid systematic review and meta-analysis. J Affect Disord. 2020;277:347–357. doi:10.1016/j.jad.2020.08.034
   PubMed Web of Science ®Google Scholar
• Akande-Sholabi W, Adebisi YA. The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study. Pan Afr Med J. 2020;35(Suppl 2):54. doi:10.11604/pamj.supp.2020.35.2.23671
   Web of Science ®Google Scholar
• Abikoye TM. Collateral damage: the impact of the COVID-19 pandemic on the care of a patient with tuberculous neuroretinitis in Lagos, Nigeria. Pan Afr Med J. 2020;35(Suppl 2):664. doi:10.11604/pamj.supp.2020.35.2.24691
   Google Scholar
• World Health Organization. Rational Use of Personal Protective Equipment for Coronavirus Disease (‎‎‎ COVID-19)‎‎‎: Interim Guidance, 27 February 2020. World Health Organization; 2020.
   Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Eng J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577
   PubMed Web of Science ®Google Scholar
• Umakanthan S, Chauhan A, Gupta MM, Sahu PK, Bukelo MM, Chattu VK. COVID-19 pandemic containment in the Caribbean Region: a review of case-management and public health strategies. AIMS Public Health. 2021;8(4):665. doi:10.3934/publichealth.2021053
   PubMed Web of Science ®Google Scholar
• Yilma D, Mohammed R, Getahun Abdela S, et al. COVID‐19 vaccine acceptability among health care workers in Ethiopia: do we practice what we preach? Tropical Med Int Health. 2022;27(4):418–425. doi:10.1111/tmi.13742
   PubMed Web of Science ®Google Scholar
• WHO. Ethiopia: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data 2022. Available from: https://covid19.who.int/region/afro/country/et. Accessed April 14, 2022.
   Google Scholar
• Sallam M, Al-Sanafi M, Sallam M, Global A. Map of COVID-19 Vaccine Acceptance Rates per Country: an Updated Concise Narrative Review. J Multidiscip Healthc. 2022;15:21. doi:10.2147/JMDH.S347669
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–228. doi:10.1038/s41591-020-1124-9
   PubMed Web of Science ®Google Scholar
• MacDonald NE, Dubé E. Unpacking vaccine hesitancy among healthcare providers. EBioMedicine. 2015;2(8):792. doi:10.1016/j.ebiom.2015.06.028
   PubMed Web of Science ®Google Scholar
• Verger P, Fressard L, Collange F, et al. Vaccine hesitancy among general practitioners and its determinants during controversies: a national cross-sectional survey in France. EBioMedicine. 2015;2(8):891–897. doi:10.1016/j.ebiom.2015.06.018
   PubMed Web of Science ®Google Scholar
• Sadique MZ, Devlin N, Edmunds WJ, Parkin D. The effect of perceived risks on the demand for vaccination: results from a discrete choice experiment. PLoS One. 2013;8(2):e54149. doi:10.1371/journal.pone.0054149
   PubMed Web of Science ®Google Scholar
• Umakanthan S, Lawrence S. Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study. Postgrad Med J. 2022. doi:10.1136/postgradmedj-2021-141365
   Web of Science ®Google Scholar
• Berghea F, Berghea CE, Abobului M, Vlad VM. Willingness to Pay for a for a Potential Vaccine Against SARS-CoV-2/COVID-19 Among Adult Persons. 2020.
   Google Scholar
• Culyer AJ. Encyclopedia of Health Economics. Newnes; 2014.
   Google Scholar
• Deal K, Marshall D, Dabrowski D, Charter A, Bukoski M, Moayyedi P. Assessing the value of symptom relief for patients with gastroesophageal reflux disease treatment: willingness to pay using a discrete choice experiment. Value Health. 2013;16(4):588–598. doi:10.1016/j.jval.2013.01.007
   PubMed Web of Science ®Google Scholar
• Palanca-Tan R. The demand for a dengue vaccine: a contingent valuation survey in Metro Manila. Vaccine. 2008;26(7):914–923. doi:10.1016/j.vaccine.2007.12.011
   PubMed Web of Science ®Google Scholar
• Yeo HY, Shafie AA. The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study. Cost Effectiveness Resource Allocation. 2018;16(1):1–10. doi:10.1186/s12962-018-0163-2
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Tran BX, Do CD, et al. Feasibility and willingness to pay for dengue vaccine in the threat of dengue fever outbreaks in Vietnam. Patient Prefer Adherence. 2018;12:1917. doi:10.2147/PPA.S178444
   PubMed Web of Science ®Google Scholar
• Muniz Junior RL, Godói IP, Reis EA, et al. Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications. Expert Rev Pharmacoecon Outcomes Res. 2019;19(4):473–482. doi:10.1080/14737167.2019.1552136
   PubMed Web of Science ®Google Scholar
• Harapan H, Mudatsir M, Yufika A, et al. Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: a cross-sectional study in Indonesia. Vaccine. 2019;37(11):1398–1406. doi:10.1016/j.vaccine.2019.01.062
   PubMed Web of Science ®Google Scholar
• Bishai D, Pariyo G, Ainsworth M, Hill K. Determinants of personal demand for an AIDS vaccine in Uganda: contingent valuation survey. Bull World Health Organ. 2004;82:652–660.
   PubMed Web of Science ®Google Scholar
• Birhane MG, Miranda MEG, Dyer JL, Blanton JD, Recuenco S. Willingness to pay for dog rabies vaccine and registration in Ilocos Norte, Philippines (2012). PLoS Negl Trop Dis. 2016;10(3):e0004486. doi:10.1371/journal.pntd.0004486
   PubMed Web of Science ®Google Scholar
• García LY, Cerda AA. Contingent assessment of the COVID-19 vaccine. Vaccine. 2020;38(34):5424–5429. doi:10.1016/j.vaccine.2020.06.068
   PubMed Web of Science ®Google Scholar
• Nunes PALD. Contingent Valuation Method; 2022. Available from: http://www.coastalwiki.org/wiki/Contingent_Valuation_Method. Accessed April 15, 2022.
   Google Scholar
• Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160. doi:10.3390/vaccines9020160
   PubMed Web of Science ®Google Scholar
• Harapan H, Wagner AL, Yufika A, et al. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum Vaccin Immunother. 2020;16(12):3074–3080. doi:10.1080/21645515.2020.1819741
   PubMed Web of Science ®Google Scholar
• Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16(9):2204–2214. doi:10.1080/21645515.2020.1790279
   PubMed Web of Science ®Google Scholar
• Carpio CE, Sarasty O, Hudson D, Macharia A, Shibia M. The demand for a COVID-19 vaccine in Africa: evidence from Kenya. 2020.
   Google Scholar
• Peretti-Watel P, Seror V, Cortaredona S, et al. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20(7):769–770. doi:10.1016/S1473-3099(20)30426-6
   PubMed Web of Science ®Google Scholar
• Alley SJ, Stanton R, Browne M, et al. As the pandemic progresses, how does willingness to vaccinate against cOVID-19 evolve? Int J Environ Res Public Health. 2021;18(2):797. doi:10.3390/ijerph18020797
   PubMed Web of Science ®Google Scholar
• Sarasty O, Carpio CE, Hudson D, Guerrero-Ochoa PA, Borja I. The demand for a COVID-19 vaccine in Ecuador. Vaccine. 2020;38(51):8090–8098. doi:10.1016/j.vaccine.2020.11.013
   PubMed Web of Science ®Google Scholar
• Catma S, Varol S. Willingness to Pay for a Hypothetical COVID-19 Vaccine in the United States: a Contingent Valuation Approach. Vaccines. 2021;9(4):318. doi:10.3390/vaccines9040318
   Web of Science ®Google Scholar
• Cerda AA, García LY. Willingness to Pay for a COVID-19 Vaccine. Appl Health Econ Health Policy. 2021;19(3):343–351. doi:10.1007/s40258-021-00644-6
   PubMed Web of Science ®Google Scholar
• Wagner AL, Boulton ML, Sun X, et al. Perceptions of measles, pneumonia, and meningitis vaccines among caregivers in Shanghai, China, and the health belief model: a cross-sectional study. BMC Pediatr. 2017;17(1):1–9. doi:10.1186/s12887-017-0900-2
   PubMed Web of Science ®Google Scholar
• Hussain A, Ali S, Ahmed M, Hussain S. The anti-vaccination movement: a regression in modern medicine. Cureus. 2018;10(7):65.
   Web of Science ®Google Scholar
• Ransing R, Dashi E, Rehman S, Chepure A, Mehta V, Kundadak GK. COVID-19 anti-vaccine movement and mental health: challenges and A way forward. Asian J Psychiatr. 2021;58:102614. doi:10.1016/j.ajp.2021.102614
   PubMed Web of Science ®Google Scholar
• Rajamoorthy Y, Radam A, Taib NM, et al. Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: a cross-sectional household survey. PLoS One. 2019;14(4):e0215125. doi:10.1371/journal.pone.0215125
   PubMed Web of Science ®Google Scholar
• Harapan H, Wagner AL, Yufika A, et al. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Public Health. 2020;2:8.
   Google Scholar
• Meszaros JR, Asch DA, Baron J, Hershey JC, Kunreuther H, Schwartz-Buzaglo J. Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol. 1996;49(6):697–703. doi:10.1016/0895-4356(96)00007-8
   PubMed Web of Science ®Google Scholar
• Hausman J. Contingent valuation: from dubious to hopeless. J Economic Perspectives. 2012;26(4):43–56. doi:10.1257/jep.26.4.43
   Web of Science ®Google Scholar